Evidence for involvement of the proteasome complex (26S) and NFκB in IL-1β-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells

Diabetes

Volumn 47, Issue 4, 1998, Pages 583-591

  Kwon, Guirn ^a   Corbett, John A ^c   Hauser, Scott ^b   Hill, Jeanette R ^a   Turk, John ^a   McDaniel, Michael L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROTEASOME; PROTEINASE INHIBITOR; TOSYLLYSYL CHLOROMETHYL KETONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; INSULINOMA; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; CYSTEINE PROTEINASE INHIBITORS; DINOPROSTONE; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1; ISLETS OF LANGERHANS; ISOENZYMES; LEUPEPTINS; MALE; MEMBRANE PROTEINS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOSYLLYSINE CHLOROMETHYL KETONE; TUMOR CELLS, CULTURED;

EID: 0031899972     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.4.583     Document Type: Article

References (41)

1. Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633, 1965
2. Nakhooda AF, Like AA, Chappel CI, Wei CN, Marliss EB: The spontaneously diabetic Wistar rat (the BB rat): studies prior to and during development of the overt syndrome. Diabetologia 14:199-207, 1978
3. Makino S, Kunimoto K. Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Exp Anim 29:1-13, 1980
4. Mandrup-Poulsen T, Bendtzen K, Nielsen JH. Bendixen G Nerup J: Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424-429, 1985
5. Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH: Mechanisms of pancreatic islet cell destruction. Allergy 41:250-259, 1986
6. Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF, McDaniel ML: Nitric oxide mediates IL-1β-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15:145-153, 1993
7. Southern C, Schulster D, Green IC: Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-a via an L-arginine-dependent nitric oxide generation mechanism. FEBS Lett 276:42-44, 1990
8. Corbett JA, Lancaster JR, Sweetland MA, McDaniel ML: Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complexed in islets of Langerhans. J Biol Chem 266:21351-21354, 1991
9. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 126:3167-3173, 1991
10. Corbett JA, McDaniel ML: Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903, 1992
11. Laychock SG, Modica ME, Cavanaugh CT: L-arginine stimulates cyclic guanosine 3′, 5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase. Endocrinology 129:3043-3052, 1991
12. Corbett JA, Kwon G, Turk J, McDaniel ML: IL-1β induces the co-expression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32:13767-13770, 1993
13. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244, 1993
14. Corbett JA, Kwon G, Marino MH, Rodi CP, Sullivan PM, Turk J, McDaniel ML: Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets of Langerhans. Am J Physiol 270:C 1581-C1587, 1996
15. Corbett JA, McDaniel ML: Intraislet release of interleukin-1 inhibits β-cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
16. Porreca E, Reale M, Febbo CD, Gioacchino MD, Babacane RC, Castellani ML, Baccante G, Conti P, Cuccurullo F: Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. Immunology 89:424-429, 1996
17. Xie Q-W. Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med 177:1779-1784, 1993
18. Herschman HR, Gilbert RS, Xie W, Luner S, Reddy ST: The regulation and role of TIS 10 prostaglandin synthase-2. Adv Prostaglandin Thromboxane Leukot Res 23:23-28, 1995
19. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NFκB1 precursor protein and the activation of NFκB. Cell 78:773-785, 1994
20. Hershko A, Ciechanover A: The ubiquitin system for protein degradation. Annu Rev Biochem 61:761-507, 1992
21. Jentsch S: The ubiquitin-conjugation system. Annu Rev Genet 26:179-207, 1992
22. Welsh N, Bendtzen K, Sandier S: Influence of protease on inhibitory and stimulatory effects of interleukin 1β on β-cell function. Diabetes 40:290-294, 1991
23. McDaniel ML, Colca JR, Kotagal N, Lacy PE: A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Method Enzymol 98:182-200, 1983
24. 15N]nitrate in biological fluids. Anal Biochem 126:131-138, 1982
25. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML: IL-1β-induced nitric oxide synthase expression by rat pancreatic β-cells: evidence for the involvement of NFκB in the signaling mechanism. Endocrinology 136:4790-4795, 1995
26. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
27. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perlons W, Lee L, Isakson P: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc Natl Acad Sci USA 91:12013-12017, 1994
28. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin. Nature 352:803-807, 1991
29. Sen R, Baltimore D: Multiple nuclear factors interact with the immuno-globulin enhancer sequences. Cell 46:705-716, 1986
30. Kwon G, Corbett JA, McDaniel ML: Interleukin-1-induced Fos and Jun do not regulate inducible nitric oxide synthase in rat islets of Langerhans and RINm5F cells. Endocrinology 137:825-830, 1996
31. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW: Signal-induced degradation of IκBa requires site-specific ubiquitination. Proc Natl Acad Sci USA 92:11259-11263, 1995
32. Traenckner EB-M, Pahl, HL Henkel T, Schmidt KN, Wilk S, Baeuerle PA: Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NFκB activation in response to diverse stimuli. EMBO J 14:2876-2883, 1995
33. Finco TS, Beg AA, Baldwin AS Jr: Inducible phosphorylation of IκBα is not sufficient for its dissociation from NFκB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 91:11884-11888, 1994
34. Mellits KH, Hay RT, Goodbourn S; Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NFκB precursor p105 are obligatory steps in the activation of NFκB. Nucleic Acids Res 21:5059-5066, 1993
35. Sun S-C, Elwood J, Beraud C, Greene WC: Human T cell leukemia virus type I tax activation of NFκB.Rel involves phosphorylation and degradation of IκB and RelA (p65)-mediated induction of the c-rel gene. Mol Cell Biol 14:7377-7384, 1994
36. Saldeen J, Welsh N: Interleukin-1β induced activation of NFκB in insulin producing RINm5F cells is prevented by the protease inhibitor Nα-P-tosyl-L-lysine chloromethylketone. Biochem Biophys Res Comm 203:149-155, 1994
37. Kim H, Lee HS, Chang KT, Ko TH, Back KJ, Kwon NS: Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol 154:4741-4748, 1995
38. Corbett JA, Sweetland MA, Wang J-L, Lancaster JR, McDaniel ML: Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 90:1731-1735, 1993
39. Flodstrom M, Welsh, N, Eizirik, DL: Cytokines activate the nuclear factor KB (NFKB) and induce nitric oxide production in human pancreatic islets. FEBS Lett 385:4-6, 1996
40. 2 inhibition of insulin secretion in HIT ceils. Diabetes 36:1047-1053, 1987
41. 2 inhibition of cAMP metabolism and phasic glucose-induced insulin secretion in HIT cells. Diabetes 38:1439-1445, 1989